PL1791530T3 - Kompozycja farmaceutyczna zawierająca psychostymulant - Google Patents

Kompozycja farmaceutyczna zawierająca psychostymulant

Info

Publication number
PL1791530T3
PL1791530T3 PL05775957T PL05775957T PL1791530T3 PL 1791530 T3 PL1791530 T3 PL 1791530T3 PL 05775957 T PL05775957 T PL 05775957T PL 05775957 T PL05775957 T PL 05775957T PL 1791530 T3 PL1791530 T3 PL 1791530T3
Authority
PL
Poland
Prior art keywords
psychostimulant
pharmaceutical composition
containing pharmaceutical
composition
psychostimulant containing
Prior art date
Application number
PL05775957T
Other languages
English (en)
Inventor
Reiner Poestges
Bernd Schneider
Richard Ammer
Original Assignee
Pejo Iserlohn Heilmittel Und Diaet Gmbh & Co Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35850133&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL1791530(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pejo Iserlohn Heilmittel Und Diaet Gmbh & Co Kg filed Critical Pejo Iserlohn Heilmittel Und Diaet Gmbh & Co Kg
Publication of PL1791530T3 publication Critical patent/PL1791530T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Neurology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL05775957T 2004-08-23 2005-08-23 Kompozycja farmaceutyczna zawierająca psychostymulant PL1791530T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP04019984 2004-08-23
EP04023039 2004-09-28
EP05775957A EP1791530B1 (en) 2004-08-23 2005-08-23 Psychostimulant containing pharmaceutical composition
PCT/EP2005/009106 WO2006021426A2 (en) 2004-08-23 2005-08-23 Psychostimulant containing pharmaceutical composition

Publications (1)

Publication Number Publication Date
PL1791530T3 true PL1791530T3 (pl) 2009-01-30

Family

ID=35850133

Family Applications (1)

Application Number Title Priority Date Filing Date
PL05775957T PL1791530T3 (pl) 2004-08-23 2005-08-23 Kompozycja farmaceutyczna zawierająca psychostymulant

Country Status (9)

Country Link
US (1) US8580301B2 (pl)
EP (2) EP2036546B1 (pl)
AU (1) AU2005276554B2 (pl)
CA (1) CA2617941C (pl)
DE (1) DE202005020881U1 (pl)
DK (2) DK2036546T3 (pl)
ES (2) ES2703874T3 (pl)
PL (1) PL1791530T3 (pl)
WO (1) WO2006021426A2 (pl)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2617941C (en) 2004-08-23 2012-07-24 Pejo Iserlohn Heilmittel Und Diaet Gmbh & Co. Kg Psychostimulant containing pharmaceutical composition
ATE536867T1 (de) 2006-03-16 2011-12-15 Tris Pharma Inc Modifizierte freisetzungsformulierungen mit arznei-ion-austausch-harzkomplexen
AU2009279372A1 (en) 2008-08-06 2010-02-11 Gosforth Centre (Holdings) Pty Ltd Compositions and methods for treating psychiatric disorders
US8840934B2 (en) 2009-01-02 2014-09-23 Rainbow Pharmaceutical Sa Uses of ammonium chloride
US8287903B2 (en) 2011-02-15 2012-10-16 Tris Pharma Inc Orally effective methylphenidate extended release powder and aqueous suspension product
GB201111712D0 (en) 2011-07-08 2011-08-24 Gosforth Ct Holdings Pty Ltd Pharmaceutical compositions
AU2013302657B2 (en) 2012-08-15 2018-08-09 Tris Pharma, Inc. Methylphenidate extended release chewable tablet
US11590228B1 (en) 2015-09-08 2023-02-28 Tris Pharma, Inc Extended release amphetamine compositions
US12458592B1 (en) 2017-09-24 2025-11-04 Tris Pharma, Inc. Extended release amphetamine tablets
US11590081B1 (en) 2017-09-24 2023-02-28 Tris Pharma, Inc Extended release amphetamine tablets

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1201136B (it) 1987-01-13 1989-01-27 Resa Farma Compressa per uso farmaceutico atta al rilascio in tempi successivi di sostanze attive
CA2223629A1 (en) 1995-07-14 1997-02-06 Nicholas Robert Pope Therapeutic use of d-threo-methylphenidate
US5837284A (en) 1995-12-04 1998-11-17 Mehta; Atul M. Delivery of multiple doses of medications
US5922736A (en) 1995-12-04 1999-07-13 Celegene Corporation Chronic, bolus administration of D-threo methylphenidate
ES2262174T3 (es) 1996-09-30 2006-11-16 Alza Corporation Forma de dosificacion y procedimiento de administracion de medicamentos.
CA2348871C (en) * 1998-11-02 2009-04-14 John G. Devane Multiparticulate modified release composition
US6673367B1 (en) * 1998-12-17 2004-01-06 Euro-Celtique, S.A. Controlled/modified release oral methylphenidate formulations
US6419960B1 (en) * 1998-12-17 2002-07-16 Euro-Celtique S.A. Controlled release formulations having rapid onset and rapid decline of effective plasma drug concentrations
US20030170181A1 (en) * 1999-04-06 2003-09-11 Midha Kamal K. Method for preventing abuse of methylphenidate
JP2002541092A (ja) * 1999-04-06 2002-12-03 ファーマクエスト・リミテッド メチルフェニデートのパルス性送達のための薬学的投薬形態
US6420473B1 (en) * 2000-02-10 2002-07-16 Bpsi Holdings, Inc. Acrylic enteric coating compositions
CA2617941C (en) 2004-08-23 2012-07-24 Pejo Iserlohn Heilmittel Und Diaet Gmbh & Co. Kg Psychostimulant containing pharmaceutical composition

Also Published As

Publication number Publication date
EP2036546A1 (en) 2009-03-18
DK2036546T3 (en) 2018-12-17
EP1791530B1 (en) 2008-08-13
DE202005020881U1 (de) 2006-12-07
AU2005276554A1 (en) 2006-03-02
US20080075769A1 (en) 2008-03-27
ES2703874T3 (es) 2019-03-12
AU2005276554B2 (en) 2011-08-25
US8580301B2 (en) 2013-11-12
ES2314693T3 (es) 2009-03-16
WO2006021426A3 (en) 2006-05-26
CA2617941C (en) 2012-07-24
DK1791530T3 (da) 2008-10-27
EP2036546B1 (en) 2018-10-10
EP1791530A2 (en) 2007-06-06
WO2006021426A2 (en) 2006-03-02
CA2617941A1 (en) 2006-03-02

Similar Documents

Publication Publication Date Title
IL177480A0 (en) Pharmaceutical composition
IL223545A0 (en) Pharmaceutical compositions
IL179809A0 (en) Pharmaceutical compositions
GB0408308D0 (en) Pharmaceutical compositions
EP1729744A4 (en) PHARMACEUTICAL PREPARATIONS
GB0426301D0 (en) Pharmaceutical formulations
IL183986A0 (en) Pharmaceutical compounds and compositions
ZA200705131B (en) Solid pharmaceutical composition comprising valsartan
ME01453B (me) Čvrste farmaceutske kompozicije koje sadrže valsartan
PL1837019T3 (pl) Kompozycja farmaceutyczna rozpadająca się w ustach
GB0416397D0 (en) Pharmaceutical formulations
HU0401177D0 (en) Pharmaceutical composition
GB2411355B (en) Pharmaceutical composition
EP1805154A4 (en) PHARMACEUTICAL COMPOSITIONS
GB0425255D0 (en) Pharmaceutical composition
ZA200701932B (en) Pharmaceutical composition
IL180316A0 (en) Quinolone-containing medicinal composition
ZA200701931B (en) Pharmaceutical composition
ZA200808768B (en) Pharmaceutical composition containing the NMB0606 protein
GB0407351D0 (en) Pharmaceutical compositions
GB0400971D0 (en) Pharmaceutical compositions
ZA200702400B (en) Psychostimulant containing pharmaceutical composition
GB0411502D0 (en) Pharmaceutical compositions
GB0502792D0 (en) Pharmaceutical compositions
GB0402799D0 (en) Pharmaceutical composition